Riskpilot← Back to searchSign inGet full accessKARDIODEX AS
ASActiveOrg 916858744Sebastian Jentschke Leilighet H0302 Fløenbakken 41C, 5009 BergenOther human health activities n.e.c. · NACE 8699Est. 20160 employees
Revenue 2024
NOK 0
EBITDA margin
—
+10% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -3K
+19% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -4K | +10% |
| Net profit | NOK -3K | +19% |
| Total assets | NOK 73K | -4% |
| Equity | NOK 73K | -4% |
| Employees | 0 | — |
Legal name
KARDIODEX AS
Org number
916858744
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
18. mars 2016
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tilby helserelaterte tjenester slik at brukerne kan få kunnskap om og gjenkjenne påvirkning av emosjonelle faktorer på deres immunstatus. Videre kan de bruke denne informasjonen til å forbedre deres helse og annet som naturlig faller sammen med dette. Tilbudet vil bli distribuert via en fellesportal på internett. Vår visjon er å gi brukerne omfattende og skreddersydde tjenester for helse og trivsel, og bli deres viktigste kontaktpunkt for spørsmål om helse og velvære. Selskapet har rett til å etablere filialer, for å delta i andre selskaper, spesielt som en generell partner, og til å etablere andre selskaper.
Address
Sebastian Jentschke Leilighet H0302 Fløenbakken 41C, 5009 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −3 | −4 | −3 | −4 | −4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −4 | −3 | −4 | −4 |
| Net financials | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | −3 | −4 | −2 | −3 | −3 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −4 | −2 | −3 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 85 | 81 | 78 | 75 | 73 |
| Equity | 85 | 81 | 78 | 75 | 73 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
-358800.0%
This company
15.8%
Market median
-2270986% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
20202024
Net profit margin
-266100.0%
This company
8.1%
Market median
-3285285% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KARDIODEX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sebastian Jentschke | Chief Executive Officer | 0 companies |
| Stefan Kölsch | Chairman | 0 companies |